Said M. Afify

1.0k total citations
40 papers, 730 citations indexed

About

Said M. Afify is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Said M. Afify has authored 40 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 28 papers in Molecular Biology and 10 papers in Biomedical Engineering. Recurrent topics in Said M. Afify's work include Cancer Cells and Metastasis (34 papers), Pluripotent Stem Cells Research (17 papers) and 3D Printing in Biomedical Research (9 papers). Said M. Afify is often cited by papers focused on Cancer Cells and Metastasis (34 papers), Pluripotent Stem Cells Research (17 papers) and 3D Printing in Biomedical Research (9 papers). Said M. Afify collaborates with scholars based in Japan, Egypt and Syria. Said M. Afify's co-authors include Masaharu Seno, Ghmkin Hassan, Akimasa Seno, Maram H. Zahra, Xiaoying Fu, Amira Osman, Juan Du, Md. Jahangir Alam, Aung Ko Ko Oo and Anna Sanchez Calle and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Cancer Research.

In The Last Decade

Said M. Afify

39 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Said M. Afify Japan 15 438 364 165 107 91 40 730
Nayoung Jun South Korea 4 607 1.4× 440 1.2× 267 1.6× 87 0.8× 81 0.9× 7 919
Sanghyun Lee South Korea 5 610 1.4× 439 1.2× 266 1.6× 87 0.8× 82 0.9× 6 923
Huizhen Suo Germany 5 398 0.9× 328 0.9× 239 1.4× 86 0.8× 101 1.1× 7 730
Karolina Sterzyńska Poland 18 428 1.0× 325 0.9× 226 1.4× 101 0.9× 101 1.1× 36 811
Lia Walcher Germany 5 395 0.9× 317 0.9× 234 1.4× 70 0.7× 94 1.0× 5 717
Shuang Yan China 17 466 1.1× 215 0.6× 135 0.8× 61 0.6× 85 0.9× 50 801
Carmen Griñán‐Lisón Spain 18 512 1.2× 342 0.9× 318 1.9× 174 1.6× 94 1.0× 39 969
Akimasa Seno Japan 19 658 1.5× 563 1.5× 203 1.2× 177 1.7× 175 1.9× 64 1.1k
Hyangsoon Noh United States 13 324 0.7× 243 0.7× 223 1.4× 58 0.5× 92 1.0× 17 649
Monica Cojoc Germany 10 487 1.1× 434 1.2× 330 2.0× 71 0.7× 71 0.8× 11 930

Countries citing papers authored by Said M. Afify

Since Specialization
Citations

This map shows the geographic impact of Said M. Afify's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Said M. Afify with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Said M. Afify more than expected).

Fields of papers citing papers by Said M. Afify

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Said M. Afify. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Said M. Afify. The network helps show where Said M. Afify may publish in the future.

Co-authorship network of co-authors of Said M. Afify

This figure shows the co-authorship network connecting the top 25 collaborators of Said M. Afify. A scholar is included among the top collaborators of Said M. Afify based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Said M. Afify. Said M. Afify is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassan, Ghmkin, Said M. Afify, Maram H. Zahra, et al.. (2023). GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation. Cytotechnology. 75(3). 243–253. 1 indexed citations
2.
Afify, Said M. & Masaharu Seno. (2023). Methods in Cancer Stem Cell Biology. 3 indexed citations
3.
Afify, Said M., Ghmkin Hassan, Maram H. Zahra, et al.. (2023). Cancer stem cells as the source of tumor associated myoepithelial cells in the tumor microenvironment developing ductal carcinoma in situ. Biomaterials. 301. 122249–122249. 5 indexed citations
4.
Afify, Said M., Ghmkin Hassan, Akimasa Seno, & Masaharu Seno. (2022). Cancer-inducing niche: the force of chronic inflammation. British Journal of Cancer. 127(2). 193–201. 71 indexed citations
5.
Afify, Said M., Juan Du, Bingbing Liu, et al.. (2022). The efficacy of PI3Kγ and EGFR inhibitors on the suppression of the characteristics of cancer stem cells. Scientific Reports. 12(1). 347–347. 14 indexed citations
6.
Minematsu, Hideki, Said M. Afify, Ghmkin Hassan, et al.. (2022). Cancer stem cells induced by chronic stimulation with prostaglandin E2 exhibited constitutively activated PI3K axis. Scientific Reports. 12(1). 15628–15628. 9 indexed citations
7.
Zahra, Maram H., et al.. (2022). Cancer Stem Cells Contribute to Drug Resistance in Multiple Different Ways. Advances in experimental medicine and biology. 1393. 125–139. 8 indexed citations
8.
Chen, Ling, Yanxia Liu, Said M. Afify, et al.. (2022). Up-regulation of Dsg2 confered stem cells with malignancy through wnt/β-catenin signaling pathway. Experimental Cell Research. 422(1). 113416–113416. 7 indexed citations
9.
Hassan, Ghmkin, Toshiaki Ohara, Said M. Afify, et al.. (2022). Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways. Journal of Experimental & Clinical Cancer Research. 41(1). 29–29. 9 indexed citations
10.
Hassan, Ghmkin, Said M. Afify, Maram H. Zahra, et al.. (2021). Chronic exposure to FGF2 converts iPSCs into cancer stem cells with an enhanced integrin/focal adhesion/PI3K/AKT axis. Cancer Letters. 521. 142–154. 22 indexed citations
11.
Hassan, Ghmkin, Said M. Afify, Juan Du, et al.. (2021). MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway. Biochemical and Biophysical Research Communications. 583. 49–55. 5 indexed citations
12.
Afify, Said M., Ghmkin Hassan, Ting Yan, Akimasa Seno, & Masaharu Seno. (2021). Cancer Stem Cell Initiation by Tumor-Derived Extracellular Vesicles. Methods in molecular biology. 2549. 399–407. 9 indexed citations
13.
Ishii, Hiroko, et al.. (2021). Isolation and characterization of cancer stem cells derived from human glioblastoma.. American Journal of Cancer Research. 11(2). 441–457. 14 indexed citations
14.
Du, Juan, Akimasa Seno, Aung Ko Ko Oo, et al.. (2020). Upregulated CCL20 and CCR6 in Cancer Stem Cells Converted from Mouse iPS Cells. Okayama University Scientific Achievement Repository (Okayama University). 8(1). 200–207. 1 indexed citations
15.
Hassan, Ghmkin, Said M. Afify, Yoshihiro Kodama, et al.. (2020). Cancer Stem Cell Microenvironment Models with Biomaterial Scaffolds In Vitro. Processes. 9(1). 45–45. 11 indexed citations
16.
Du, Juan, Aung Ko Ko Oo, Ghmkin Hassan, et al.. (2020). Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment. Scientific Reports. 10(1). 9955–9955. 18 indexed citations
17.
Afify, Said M., Anna Sanchez Calle, Ghmkin Hassan, et al.. (2020). A novel model of liver cancer stem cells developed from induced pluripotent stem cells. British Journal of Cancer. 122(9). 1378–1390. 45 indexed citations
18.
Osman, Amira, Said M. Afify, Ghmkin Hassan, et al.. (2020). Tumor-associated macrophages derived from cancer stem cells. Acta Histochemica. 122(8). 151628–151628. 16 indexed citations
19.
Osman, Amira, Said M. Afify, Ghmkin Hassan, et al.. (2020). Revisiting Cancer Stem Cells as the Origin of Cancer-Associated Cells in the Tumor Microenvironment: A Hypothetical View from the Potential of iPSCs. Cancers. 12(4). 879–879. 47 indexed citations
20.
Afify, Said M., Ghmkin Hassan, Maram H. Zahra, et al.. (2020). Paclitaxel and Sorafenib: The Effective Combination of Suppressing the Self-Renewal of Cancer Stem Cells. Cancers. 12(6). 1360–1360. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nayoung Jun Breakdown of academic impact, for papers by Sanghyun Lee Breakdown of academic impact, for papers by Huizhen Suo Breakdown of academic impact, for papers by Karolina Sterzyńska Breakdown of academic impact, for papers by Lia Walcher Breakdown of academic impact, for papers by Shuang Yan Breakdown of academic impact, for papers by Carmen Griñán‐Lisón Breakdown of academic impact, for papers by Akimasa Seno Breakdown of academic impact, for papers by Hyangsoon Noh Breakdown of academic impact, for papers by Monica Cojoc
Rankless by CCL
2026